FLGT
Fulgent Genetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$19.73
+0.41%Margins
Gross margin
35.6%
EBITDA margin
-20.1%
EBIT margin
-37.1%
Net margin
-26.0%
FCF margin
-32.0%
-8.4%
Return on equity
-7.7%
Return on assets
-11.9%
Return on invested capital
0.29x
Asset turnover
-$83.7M
Cash from operations
$9.34
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026